ATE283042T1 - Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel - Google Patents
Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittelInfo
- Publication number
- ATE283042T1 ATE283042T1 AT99962490T AT99962490T ATE283042T1 AT E283042 T1 ATE283042 T1 AT E283042T1 AT 99962490 T AT99962490 T AT 99962490T AT 99962490 T AT99962490 T AT 99962490T AT E283042 T1 ATE283042 T1 AT E283042T1
- Authority
- AT
- Austria
- Prior art keywords
- diisopropylphenol
- dianhydro
- glucitol
- solvents
- methyl
- Prior art date
Links
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003182 parenteral nutrition solution Substances 0.000 title 1
- 239000002904 solvent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 1
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- 238000001949 anaesthesia Methods 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN65BO1999 | 1999-01-28 | ||
| PCT/IN1999/000044 WO2000044369A1 (en) | 1999-01-28 | 1999-09-13 | Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE283042T1 true ATE283042T1 (de) | 2004-12-15 |
Family
ID=11077269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962490T ATE283042T1 (de) | 1999-01-28 | 1999-09-13 | Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6071974A (de) |
| EP (1) | EP1143962B1 (de) |
| CN (1) | CN1151782C (de) |
| AT (1) | ATE283042T1 (de) |
| AU (1) | AU1888700A (de) |
| DE (1) | DE69922252T2 (de) |
| ES (1) | ES2232195T3 (de) |
| PT (1) | PT1143962E (de) |
| WO (1) | WO2000044369A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1105096B1 (de) | 1998-08-19 | 2003-10-29 | Skyepharma Canada Inc. | Injizierbare wässerige propofoldispersionen |
| IN188917B (de) * | 2000-12-07 | 2002-11-23 | Bharat Surums & Vaccines Ltd | |
| AU2003260943A1 (en) * | 2003-06-10 | 2005-01-04 | Shashikant Prabhudas Kurani | Improved novel, clear, painless preparation of propofol |
| US20080171687A1 (en) * | 2004-09-16 | 2008-07-17 | Abraxis Bioscience, Inc. | Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
| CA2880727C (en) | 2005-08-31 | 2019-05-07 | Neil P. Desai | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| KR101643416B1 (ko) * | 2005-08-31 | 2016-07-27 | 아브락시스 바이오사이언스, 엘엘씨 | 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9405593D0 (en) * | 1994-03-22 | 1994-05-11 | Zeneca Ltd | Pharmaceutical compositions |
| MX9701342A (es) * | 1994-09-01 | 1997-05-31 | Upjohn Co | Formulacion cosolvente de tirilazad para administracion parenteral. |
| IL115742A (en) * | 1994-10-26 | 2000-06-01 | Novartis Ag | Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant |
| US5637625A (en) * | 1996-03-19 | 1997-06-10 | Research Triangle Pharmaceuticals Ltd. | Propofol microdroplet formulations |
| CH692322A5 (it) * | 1997-05-26 | 2002-05-15 | Westy Ag | Formulazione iniettabile limpida di Propofol. |
-
1999
- 1999-09-13 PT PT99962490T patent/PT1143962E/pt unknown
- 1999-09-13 EP EP99962490A patent/EP1143962B1/de not_active Expired - Lifetime
- 1999-09-13 ES ES99962490T patent/ES2232195T3/es not_active Expired - Lifetime
- 1999-09-13 DE DE69922252T patent/DE69922252T2/de not_active Expired - Lifetime
- 1999-09-13 WO PCT/IN1999/000044 patent/WO2000044369A1/en not_active Ceased
- 1999-09-13 CN CNB998162523A patent/CN1151782C/zh not_active Expired - Fee Related
- 1999-09-13 AT AT99962490T patent/ATE283042T1/de active
- 1999-09-17 AU AU18887/00A patent/AU1888700A/en not_active Abandoned
- 1999-09-22 US US09/401,057 patent/US6071974A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2232195T3 (es) | 2005-05-16 |
| US6071974A (en) | 2000-06-06 |
| DE69922252T2 (de) | 2005-12-01 |
| CN1334725A (zh) | 2002-02-06 |
| EP1143962B1 (de) | 2004-11-24 |
| PT1143962E (pt) | 2005-03-31 |
| DE69922252D1 (de) | 2004-12-30 |
| CN1151782C (zh) | 2004-06-02 |
| AU1888700A (en) | 2000-08-18 |
| EP1143962A1 (de) | 2001-10-17 |
| WO2000044369A1 (en) | 2000-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0117583D0 (en) | Novel compounds | |
| CA2326655A1 (en) | Disinfecting compositions and processes for disinfecting surfaces | |
| DE69739049D1 (de) | Flüssigkristallverbindungen, Flüssigkristalle enthaltende Zubereitungen, und aus diesen Verbindungen hergestellte Flüssigkristallanzeigen | |
| EA200601830A1 (ru) | Ортозамещённые арильные или гетероарильные амидные соединения | |
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| PT1075259E (pt) | Novos analogos gordos para o tratamento de diabetes | |
| GB0015601D0 (en) | Novel antidiuretic agents | |
| AU2002317829A1 (en) | Photostable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | |
| WO2007099162A3 (fr) | Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques | |
| AU1085492A (en) | New n-myristoyltransferase inhibitors, process for preparing these and pharmaceutical compositions containing them | |
| EA200501148A1 (ru) | Пиридилоксиметильные и бензизоксазольные азабициклические производные | |
| ATE283042T1 (de) | Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel | |
| BRPI0416474A (pt) | uso de um composto, composição, e compostos | |
| AR053559A1 (es) | Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados | |
| MY140325A (en) | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
| SE0001865D0 (sv) | Management of septic shock | |
| WO1999023092A3 (en) | 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them | |
| EP1390343A4 (de) | Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält | |
| ATE477263T1 (de) | Zusammensetzung enthaltend ferrocen-derivate und treibstoff diese enthaltend | |
| CA2440186A1 (en) | Medicinal composition containing 1,3-thiazine derivative | |
| EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
| IL159841A0 (en) | Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1143962 Country of ref document: EP |